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Summary
Transforming growth factor a (TGF-a) is a pleuripotential cytokine with diverse biological effects,
including the ability to influence the proliferation of normal cells or neoplastic epithelial cells.
Eosinophils are a subset of granulocytes that normally enter the peripheral tissues, particularly
those beneath gastrointestinal, respiratory, and urogenital epithelium, where they reside in close
proximity to the epithelial elements. In this study, we demonstrate that the great majority of
eosinophils infiltrating the interstitial tissues adjacent to two colonic adenocarcinomas and two
oral squamous cell carcinomas labeled specifically by in situ hybridization with a 35S-riboprobe
for humanTGF-a (hTGF-a). No other identifiable leukocytes in these lesions contained detectable
hTGF-a mRNA. We also examined leukocytes purified from a patient with the idiopathic
hypereosinophilic syndrome. 80% of these eosinophils, but none of the patient's neutrophils
or mononuclear cells, were positive for hTGF-a mRNA by in situ hybridization, and 55% of
these eosinophils were positive by immunohistochemistry with a monoclonal antibody directed
against the COOH terminus of the mature hTGF-a peptide. Finally, the identification of the
purified eosinophil-associated transcript as hTGF-ca was confirmed by polymerase chain reaction
product restriction enzyme analysis followed by Southern blot hybridization. In contrast to
eosinophils from the patient with hypereosinophilic syndrome, the peripheral blood eosinophils
from only two of seven normal donors had detectable TGF-amRNA and none ofthese eosinophils
contained immunohistochemically detectableTGF-aproduct. Takentogether, these findings establish
that human eosinophils can express TGF-a, but suggest that the expression of TGF-aby eosinophils
may be under microenvironmental regulation. Demonstration of TGF-a production by tissue-
infiltrating eosinophils and the eosinophils in the hypereosinophilic syndrome identifies a novel
mechanism by which eosinophils might contribute to physiological, immunological, and patho-
logical responses.
Transforming growth factor a (TGF-a) is a 50 amino acid
peptide that was initially discovered as an activity in
retrovirus-transformed cells that can compete with epidermal
growth factor (EGF)t for binding to the EGF-receptor (1).
Most malignant epithelial tumors have been found to express
TGF-a (2), which may contribute to the transformed pheno-
types ofthese cells through autocrine mechanisms (3). More
recently, TGF-a has been demonstrated in certain normal
tissues and cell types as well, including normal human skin
1 Abbreviations used in this paper: DAPI, 4',6-diamidino-2-phenylindole;
EGF, epidermal growth factor; h, human; mRNA, messenger RNA.
keratinocytes (4, 5), bovine anterior pituitary cells (6), rat
material decidua (7), mouse blastocysts (8), and activated mac-
rophages (9, 10). These findings suggest that TGF-a is not
only involved in neoplasms but may also contribute to inter-
actions among normal cells, possibly through autocrine and/or
paracrine mechanisms (11).
The studies described herein were prompted by an unex-
pected observation made during an investigation of mRNA
for the cytokine TGF-a in experimental oral carcinomas in
Syrian hamsters (12, 13). When in situ hybridization was
used to identify the cellular localization of TGF-a mRNA
in these lesions, we found that a significant fraction of the
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labeled (Elovic, A., S . J . Galli, P . F . Weller, et al., unpub-
lished data) . Eosinophils are a distinct lineage of granulo-
cytes that arise in the bone marrow, circulate in the blood,
andemigrate into peripheral tissues (14) . Although eosinophils
normally represent only ti3%a of circulating leukocytes in
humans, large numbers of eosinophils ordinarily reside in cer-
tain tissues . In fact, the peripheral tissues rather than the blood
andbone marrow contain themajority ofmature eosinophils,
which are especially abundant near the mucosal surfaces of
gastrointestinal, respiratory, and genitourinary tracts (14) .
Moreover, greatly increased numbers of eosinophils appear
in the blood and tissues in association with a variety of im-
mune responsesor disease processes (14, 15). In some ofthese
responses, such as immune reactions to helminthic parasites,
eosinophils function as effectors ofhost defense (16) . In other
settings, eosinophil-derived mediatorsprobably contribute to
the pathogenesis of disease (15) . In yet other reactions, such
as host responses to neoplasms (17-21), the specific role of
the eosinophil remains obscure .
Because TGF-a is amultifunctional cytokine that has been
implicated in the regulation of proliferation of both normal
and neoplastic cells (3), as well as in other processes such
as angiogenesis (22), we believed that it would be of interest
to determine whetherhuman eosinophils could elaborate this
cytokine . We therefore used in situ hybridization to search
for the expression ofTGF-amRNA in eosinophils infiltrating
the interstitial tissues adjacent to human colonic or oral car-
cinomas. We also used in situ hybridization, Northern blot-
ting, PCR product restriction enzyme analysis, RIA, and
immunohistochemistry to demonstrate TGF-amRNA and
product in eosinophils from patients with the idiopathic
hypereosinophilic syndrome.
Materials and Methods
Eosinophil-rich Human Tumors.
￿
Four freshly resected human co-
lonic adenocarcinomas and 10 oral carcinomas were obtained from
the Pathology Department at the Beth Israel Hospital, and the
Department of Oral and Maxillofacial Surgery at the Massachusetts
General Hospital, respectively. They were immediately fixed in
freshly prepared4% paraformaldehye and then processed for paraffin
embedding. Representative sections from each of these tumors were
examined for the presence of eosinophils in the stroma . Two of
the colonic adenocarcinomas and two of the oral carcinomas con-
tained many stromal eosinophils . These four eosinophil-richhuman
tumor specimens were used for in situ hybridization studies .
Human Eosinophil Isolation .
￿
Granulocytes were isolated from the
sodium citrate anticoagulated blood of patients with idiopathic
hypereosinophilic syndrome by dextran sedimentation, centrifuga-
tion through Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway,
NJ), andhypotonic lysis oferythrocytes (23) . Unfractionated gran-
ulocytes were used for the in situ hybridization and immuno-
histochemistry studies . For PCR, Northern blot analyses, and
TGF-aRIA, granulocytes were enriched for eosinophilsby sequen-
tial incubation at 4°C with the anti-CD-16 mAb Leu11a (Becton
Dickinson& Co ., Mountain View, CA) andmagnetic beads con-
jugated with goat anti-mouse IgG (Advanced Magnetics, Cam-
bridge, MA) to deplete CD16' neutrophils. Leukocytes were also
isolated by dextran sedimentation from the peripheral blood ofseven
healthymale donors, aged 27-44yr. These preparations consisted
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of 1-5% eosinophils, 52-83% neutrophils, and 16-55% mono-
nuclear cells .
Cell Culture .
￿
TheTGF-a-producing humanA431 epidermoid
carcinoma cell line was maintained at 37°C, 5% C02 inDMEM
medium supplemented with 10% FCS and antibiotics (penicillin
100 U/ml, streptomycin 100 ug/ml, amphotericin B 0.25 ug/ml)
(Gibco Laboratories, Grand Island, NY) .
RNA Isolation andNorthern Blot Hybridization.
￿
TotalRNAwas
isolated from human eosinophils and A431 cells using the guani-
dine isothiocyanate method described by Davis et al . (24) . Details
of Northern blot analysis using the Zetabind membrane were de-
scribed previously (25) . Random priming was used to label the
cDNA inserts.
Molecular Probes.
￿
hTGF-ac cDNA is a 0.9-kb EcoRI fragment
obtained from G.I . Bell of Chiron Corp. (Emeryville, CA). The
chicken (0-actin cDNA is a 1.7-kb PstI fragment obtained from
D.W. Cleveland, San Francisco, CA (26) .
TGEamRNA Phenotyping .
￿
We used themRNA phenotyping
procedure of Rappolee et al . (10) . A primer-extended hTGF-a-
specific cDNA was constructed using a 21-mer hTGF-a-specific
primer (3'-CGACGGTGAGTCTTTGTCACC-5') from nucleotide
position 492 to 512 according to thenumberingsystem by Derynck
et al . (27) . The resultant cDNA was analyzed for the presence of
hTGF-a sequences by the use of two hTGF-a-specific primers (5'
primer : 22-mer 5'-GGCCTTGGAGAACAGCACGTCC-3' from
nucleotide position 97 to 118 ; 3' primer : 20-mer 3' GCTCTT
CGGGTCGCGGGAGG-5'from nucleotide position 454 to 473),
flanking the coding sequence of the mature TGF-a (nucleotide po-
sition 151 to 300). The 3' primer is 19-bp upstream to the primer
used for thecDNA library construction . The expected size of the
hTGF-a PCR product is 377 bp .
In Situ Hybridization.
￿
Details ofour in situ hybridization pro-
cedure using the antisense and sense hTGF-ca riboprobes were de-
scribed previously (13) . Immediately following isolation, blood leu-
kocytes or purifiedhuman eosinophils were embedded into1% agar
in 1x PBS and then fixed, processed, and embedded in paraffin
as previously described (13) .
Two reports indicate that under some conditions of hybridiza-
tion, eosinophils can nonspecifically bind DNA(28) or RNA (29)
probes used for in situ hybridization . We thereforeperformed pre-
liminary experiments to define experimental conditions allowing
the specific labeling ofeosinophilmRNA by in situ hybridization .
We found that hybridization at temperatures of<50°C and/or du-
rations of<12h resulted in nonspecific labeling ofeosinophils. How-
ever, such nonspecific binding did not occur when sections of
paraformaldehyde-fixed, paraffin-embedded tissues were incubated
in a prehybridization solution containing S-UTP-labeled cold probe
for at least 2 h at 42°C, and when RNaseA and T1 were used
in posthybridization washes . For thework reported here, sections
were prehybridized for 2 h at 42°C in the presence of S-UTP-
labeledpGEM3 single-strandedRNA. Hybridization was at 50°C
for 12 h .
Immunohistochemistry .
￿
Blood leukocytes or purified eosinophils
were prepared as described for in situ hybridization . The paraffin-
embedded sections (6 1.tm) were subjected to staining forhTGF-a
protein usingamAb directed against theCOOH terminus (residues
34-50) ofthe mature 50 amino acid hTGF-a peptide (TGF-a : Ab-2 ;
GF-10; Oncogene Science, Manhasset, NY). 12 Ftg/ml ofthemAb
was used to stain each section . A mAb to the bacterial protein
a-galactosidase (Ab-1; OB02 ; Oncogene Science) at thesame con-
centration was used as a negative control. The Vectastain ABC-
alkaline phosphatase (mouse IgGAK5002) and alkaline phospha-
tase substrate I (SK-5100) (Vector Laboratories, Burlingame, CA)
in Human Eosinophilsin the presence of 1.25 mM oflevamisole (SP-5000) were used for
signal detection. All sections were stained with 0.2% aniline blue
for 10 min to identify eosinophils (30).
TGF-a RM.
￿
A TGF-a RIA kit from Biotope (Redmond, WA)
was used to determine the presence of immunoreactive TGF-a in
the supernatants from eosinophils ofhypereosinophilic donors. The
immunogen was a synthetic peptide conjugate ofthe COOH-ter-
mina117 residues (34-50) of rat TGF-a. Tracers and standards are
made from bioactive synthetic rat TGF-a. The assaydoes not cross-
react with rodent or human EGF. Appropriate controls indicated
that the concentrated supernatants did not affect assay of 5 nM
TGF-a standard or alter nonspecific binding (0.8%) .
Results
Eosinophils in Human Carcinomas Contain TGF-a mRNA.
Our finding that eosinophils infiltrating into developing ham-
ster oral carcinomas express TGF-a prompted us to deter-
mine if eosinophils infiltrating into human cancer could
elaborate this cytokine. It is well known that human colonic
adenocarcinomas and oral carcinomas are frequently associated
with eosinophil-rich inflammatory infiltrates (18-21). Four
freshly resected human colonic adenocarcinomas and 10 human
oral squamous cell carcinomas were obtained. Two tumors
from each of these anatomical sites contained many stromal
eosinophils. These four specimens were used for in situ hy-
bridization studies.
Eosinophils in the connective tissue adjacent to each of
the four human tumors hybridized specifically with the I'S-
labeled antisense hTGF-a riboprobe, whereas hybridization
of contiguous sections with the 35S-labeled sense hTGF-a
riboprobe demonstrated no specific labeling. Fig. 1, A-H,
shows the in situ TGF-oc mRNA labeling results from one
of the two eosinophil-rich human colonic adenocarcinoma
specimens. A to D are photomicrographs taken from a sec-
tion of normal mucosa adjacent to the colonic adenocarci-
noma hybridized with the "S-labeled antisense hTGF-a
riboprobe. A is the bright-field view of this tumor demon-
strating cellsin the lamina propria labeling prominently with
the 35S-labeled antisense hTGF-a riboprobe. The identity of
these labeled cellscannot be easily recognizedfrom this pho-
tomicrograph. Fig. 1 B is the same field photographed with
dark-field illumination and a green filter highlighting the au-
toradiographic grains. To define further the identity of the
labeled cells, we exploited the fact that the eosinophilic cyto-
plasmic granules exhibit an autofluorescence that is much more
intense than that of any other nucleated cell (31). We found
that human eosinophils stained with a Fisher Giemsa stain
and viewed with rhodamine filters at 552 nm exhibited an
especially brilliant red fluorescence, as shown in Fig. 1 C.
Fig. 1 D is a composite exposure demonstrating that most
of the cell-hybridized TGF-a-specific autoradiographic grains
were localized to the fluorescent cells. Analysis ofsuch prepa-
rations indicated that -90% of infiltrating eosinophils la-
beled with the 35S-labeled antisense KfGF-a riboprobe. E-H
show a contiguous section of the same specimen hybridized
with the 35S-labeled sense hTGF-a riboprobe. No specific au-
toradiographic signals are localized to any of the cells in this
section.
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TGRa mRNA Phenotyping and Characterization in Purified
Human Eosinophbfrom a HypereosinophilicPatient. An hTGF-
a-specific, primer-extended cDNA library was constructed
by the mRNA phenotyping procedure (10), using total RNA
isolated from a purified human eosinophil preparation (74%
eosinophils and 26% neutrophils). Total RNA from the
human epidermoidcarcinoma A431 cell line, which is known
to contain TGF-a mRNA, was used as a positive control
(2). The resultant cDNA libraries were subjected to the PCR
to search for TGF-a sequences. The two primers specific for
human TGF-a used for the PCR reaction flank the coding
sequence of the mature TGF-a and should produce a 377-bp
PCR product if authentic human TGF-a cDNA is present.
Lanes 1 and 7 in Fig. 2 demonstrate that a -377-bp PCR
product was detected in both the human eosinophil and A431
cells. The negative control lanes 4-6 contain all the reagents
except for the starting human eosinophil or A431 cell RNA
templates. To demonstrate the specificity ofthe PCR product,
we used the fact that the human TGF-a sequence has a Pvull
site 37by upstream from the 3' end ofthe 377-bp PCR product
(27). Upon subjecting the respective PCR products to a Pvull
cut, we observed a slight but definite decrease in size of the
parental band to -340 by (the other, 72-bp product is too
small to be resolved discretely by the 2% agarose gel used).
This finding supports the identification of the TGF-a PCR
product as derived from human TGF-a. We next subjected
the PCR products to a PstI digestion because there are two
PstI sites within the coding sequence for mature TGF-a (27).
Pstl digestion of the 377-bp hTGF-a-PCR product there-
fore should give rise to three fragments with sizes of 52, 67,
and 258 bp. Lanes3 and 9 in Fig. 2 demonstrate the appear-
ance of the predicted 258-bp Pstl-digested fragments in both
the HE and A431 samples (the 52- and 67-bp Pstl digested
fragments are too small to be resolved discretely by the 2%
agarose gel used). Subsequent Southern blot hybridization
with a 31p-labeled human TGF-a cDNA revealed that the
parental, Pvull-digested, and PstI-digested PCR products in
both human eosinophils and A431 cells hybridized specifically
at the expected locations (data not shown). These results dem-
onstrate both the presence of human TGF-a mRNA in the
preparation ofpurified human eosinophils and that the coding
sequence of the mature cytokine is part of the expressed se-
quence.
Detection ofTGRa mRNA in Human Eosinophih by Northern
Blotting. We then determined whether specific TGF-a
mRNA sequences could be detected by Northern blot hy-
bridization in total RNA derived from the same human eo-
sinophil preparation used for PCR analysis. Using a 32p-
labeled human TGF-a cDNA probe, a TGF-a hybridizable
RNA band was detected at -4.5 kb (Fig. 3), identical in
size to the TGF-a hybridizable RNA band in the A431 cells
(2). Hybridization of the same blot with a 31P-labeled
chicken /3-actin cDNA revealed that approximately the same
amount of RNA had been loaded onto each lane and that
the quality of the isolated RNA was satisfactory.
Localization of TGRot mRNA to Human Eosinophils by In
Situ Hybridization. Although human eosinophils can be iso-
lated in purities of >75%, residual contamination by other676
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Human TGF-a mRNA phenotyping and characterization
of total RNA isolated from a human eosinophil preparation (see
text) . (Lanes 1-3) HE, human eosinophils; (lanes 4-6) negative con-
trol (no RNA templates) ; (lanes 7-9) A431, human epidermoid carci-
noma cell line. (lanes 1, 4, and 7) PCR products of respective
samples . (Lanes 2, S, and 8) PvuII digestion of respective PCR prod-
ucts . (Lanes 3, 6, and 9) Pstl digestion of respective PCR products .
M, WX-174 HaeIII-digested molecular weight DNA markers electro-
phoresed at the same time on this 2% agarose gel (£corn top to bottom :
1,353, 1,078, 872, 603, 310, 281, 271, 234, 194, 118, and 72 bp) .
granulocytes (almost exclusively neutrophils) is a common
finding. The human eosinophil preparation used for PCR
and Northern blot analyses contained 74% eosinophils, with
neutrophils representing the only identifiable contaminating
cells. To localize precisely the cellular source(s) oftheTGF-a
mRNA detected in the human eosinophil preparation, we
performed in situ hybridization on unfractionated blood leu-
kocytes from the same patient (Fig. 4) . This preparation con-
tained 56% eosinophils, 29% neutrophils, 15% mononuclear
cells . 80% of theYeosinophils hybridized with the 3IS-labeled
antisense hTGF-a riboprobe . No neutrophils, monocytes,
or lymphocytes were detectably labeled with this probe. No
cells were seen labeled with the 3IS-labeled sense hTGF-CI
riboprobe on contiguous sections . A-D in Fig. 4 are from
a Giemsa-stained section demonstrating typical hybridization
with a 35S-labeled antisense hTGF-a riboprobe . The bright-
field photomicrograph in Fig. 4 A shows two cells with bi-
or multi-lobulated nuclei . The one with eosinophilic cyto-
Figssre 3 .
￿
Detection of TGF-a
transcripts in preparations of
human eosinophils (HE) and
human A431 epidermoid carci-
noma cells. 12 Ag of total
RNA was loaded onto each
lane. The full-length blot was
hybridized to a 32P-labeled
IiMfLoi cDNA . The size of
the detected TGF-a hybridiz-
able bands is -4.5 kb . The
arrows labeled 18S (N2 kb)
and 28S (N5 kb) show the po-
sitions of ribosomal RNA
markers that were electropho-
resed at the same time. The
same blot was rehybridized to
a 32P-labeled chicken P-actin
shown in the lower blot. The
size of the detected human
/4-actin transcript is ^"2 kb,
plasm (upper right) was prominently labeled with the riboprobe,
which is especially apparent in the dark-field photomicro-
graph viewed with a green filter (Fig. 4 B) . Giemsa fluores-
cence was used to confirm the identification of eosinophils
(Fig. 4 C) . Notice that only the cell in the upper right ex-
hibits fluorescence. A double exposure simultaneously demon-
strating fluorescence and in situ hybridization labeling confirms
that the labeled cell is an eosinophil (Fig. 4D) .By morphology,
the unlabeled cell is a neutrophil . E-H show a similar sec-
tion hybridized to the control 3IS-labeled sense hTGF-a
riboprobe . The two cells in the field have eosinophilic cyto-
plasm and exhibit fluorescence, but neither labeled with the
I35S)hTGF-a sense riboprobe. These findings demonstrate
the specificity of our in situ hybridization results identifying
TGF-a mRNA in human eosinophils.
Detection of7GRa-Protein inHuman Eosinophib by Immuno-
histochemistry . To determine ifTGF-a mRNAs detected in
eosinophils were translated into TGF-a protein, immuno-
Figure 1 .
￿
Detection of TGF-a mRNA in human eosinophils associated with colonic adenocarcinoma by in situ hybridization. (A and D) Sec-
tion of normal colonic mucosa immediately adjacent to the adenocarcinoma hybridized to a 35S-labeled antisense hTGF-a riboprobe. (E-FI) hy-
bridized to a 35S-labeled sense hTGF-a riboprobe . Exposure time was for 48 h at 4°C . Original magnification x12 . (A and E) Bright-field visu-
alization . (B and F) Dark-field visualization highlighting the autoradiography using a green filter. Notice a nonspecific faint green fluorescence
from all of the cells present . (C and G) Fluorescence visualization using rhodamine filters demonstrating the fluorescence of human eosinophils.
(D and H) Double exposure visualization, first with dark-field followed by rhodamine fluorescence.
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￿
Localization of cellular sources of TGF-a transcripts in the human eosinophil preparation (see text) . (A to D) Hybridized to a 35S_
labeled antisense hTGF-a riboprobe . (E to H) Hybridized to a 35S-labeled sense hTGF-a riboprobe . Exposure time was for 48 h at 4°C . Original
magnification, x500 . (A and E) bright-field visualization. (B and F) Dark-field visualization using a green filter to highlight the autoradio-
graphic grains. Notice a nonspecific faint green fluorescence associated with all of the cells. (C and G) Fluorescence visualization using rhoda-
mine filter demonstrating fluorescence in the eosinophils . (D and H) Double exposure visualization, first with dark-field followed by rhodamine
fluorescence .
histochemistry was performed on paraffin-embedded sections
ofhuman eosinophil preparation using amAb directed against
the COOH terminus (residues 34-50) of the 50 amino acid
mature sequence ofUGF-a . All sections were counterstained
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with a 0.2% aniline blue solution . Eosinophil cytoplasmic
granules stained with this dye emit a blue fluorescencewhen
viewed with a DAPI filter at 365 nm (30) . Moreover, we
find that the aniline blue fluorescence ofeosinophil cytoplasmicFigure 5 .
￿
Immunohistochemical detection of HIGF-a protein in
human eosinophils . (A and B) stained with a HPGF-a mAb at 12
p,g/ml . (C and D) stained with a control (bacterial 0-galactosidase)
mAb at 12 p.g/ml . Magnification x500 . (A and C) Bright-field visu-
alization . (B and D) Visualization of aniline blue fluorescence of eo-
sinophils by fluorescent microscopy at 365 nm with DAPI filter.
Only the eosinophils demonstrate staining with the hTGF-a mAb.
Eosinophils do not stain with the control mAb .
granules is not abolished by the red substrate staining of our
immunohistochemical procedure. As a result, both procedures
can be used on the same preparation to determine specifically
whether eosinophils contain detectable TGF-a protein .
Approximately 55% of all aniline blue fluorescent eo-
sinophils were stained by the hTGF-a mAb. No nonfluores-
cent cells (i .e ., neutrophils and mononuclear cells) were de-
tectably stained by the hTGF-a mAb . Staining of similar
preparations with the control mAb (bacterial /3-galactosidase)
resulted in no detectable staining of eosinophils or any other
cells.A andB in Fig. 5 show a section stained with the hTGF-a
mAb detected with an alkaline phosphatase method. Fig. 5
A is a bright-field photomicrograph showing that one ofthe
two cells in the field is positive for the red reaction product .
Viewing the same field with DAPI filters at 365 nm (Fig.
5 B) clearly shows that only the hTGF-a mAb positive cell
(on the left) exhibits blue fluorescence. This finding estab-
lishes the identity of the TGF-ci positive cell as an eosino-
phil . C and D in Fig . 5 show a similar section containing
two cells with bi- or multi-lobulated nuclear morphology
stained with the control mAb (bacterial a-galactosidase) . Fig .
5 C shows that no immunohistochemical positivity was ob-
served in either of these cells . Fig. 5 D shows that one of
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the two cells exhibits aniline blue fluorescence and is thus
an eosinophil.
Assay of TGF-cx Activity in Supernatants of Human Eo-
sinophij s . We investigated whether eosinophils released de-
tectable TGF-a peptide by using a commercial TGF-a RIA
kit (Biotope, Redmond, WA) . Eosinophils from two patients
with hypereosinophilic syndrome (purified to 62 and 100%)
were cultured at 5 x 10 5 cells/ml in RPMI 1640 for 18 h .
Cell-free supernatants were concentrated against anAmicon
YM-2 membrane and assayed for TGF-ci by theTGF-a RIA
kit . The amounts of TGF-ci in the two supernatants were
equivalent to 0.19 and 0.08 nM of rat TGF-ca . These data
indicate that eosinophils purified from patients with the hy-
pereosinophilic syndrome release TGF-a when cultured in
vitro .
TGF-a mRNA and Product in Eosinophils from Healthy
Donors. For each of the seven normal donors, 400 periph-
eral blood leukocytes, containing 1-5% eosinophils, were ex-
amined for TGF-amRNA and product, exactly as described
above for the cells of the hypereosinophilic patient . None
of the eosinophils, nor any other leukocyte in these speci-
mens, exhibited detectable TGF-ca product by immuno-
histochemistry (data not shown) . When in situ hybridiza-
tion results were examined in specimens exposed for 24 h,
under conditions in which TGF-amRNA was detected in
80% of the eosinophils from the patient with the hypereo-
sinophilic syndrome, no eosinophils or other cells were posi-
tive for TGF-ci mRNA . When the exposure was extended
to 7 d, TGF-a mRNA positive eosinophils were detected
in two of the seven preparations . In these two specimens,
TGF-amRNApositive eosinophils accounted for 67 and80%
of the total eosinophils identified in the same preparation by
Giemsa-enhanced fluorescence (data not shown) . No cell type
other than the eosinophil was positive for TGF-ac mRNA
after 7-d exposure of all seven preparations (data not shown) .
Discussion
This report presents several lines of evidence demonstrating
that human eosinophils can express TGF-a . TGF-ci mRNA
was detected by in situ hybridization in the eosinophils
infiltrating interstitial tissues adjacent to each of the four
different carcinomas tested (two adenocarcinomas of the colon,
two squamous cell carcinomas of the oral cavity) . To confirm
the results obtained with tissue eosinophils, we examined eo-
sinophils isolated from a patient with the hypereosinophilic
syndrome. By Northern blotting, purified eosinophils ex-
hibited a TGF-a hybridizable RNA band of the same size
(-4.5 kb) as that detected in the human A431 carcinoma
cell line, a population known to contain TGF-ci mRNA (2) .
The identification of the eosinophil-associated transcript as
TGF-ca was confirmed by PCR product restriction enzyme
analysis followed by Southern blot hybridization . Using su-
pernatants of eosinophils purified from two patients with the
hypereosinophilic syndrome, we detected TGF-ca by RIA .
Comparable amounts were detected by an EGF receptor ra-
dioassay (data not shown) . Finally, the potential cellular sourcesof TGF-ci in the purifiedhuman eosinophil preparations were
assessed by in situ hybridization and by immunohistochemistry
with amAb specific for the COOH terminus of the mature
hTGF-a peptide . By either in situ hybridization or immuno-
histochemistry, only eosinophils were positive for TGF-a
mRNA or product .
The detection ofTGF-a cytokine expression inhuman eo-
sinophils is a novel finding . Examination ofhuman hemato-
poietic cell lines, including the HD60 promyelocytic leukemia
cell line, did not reveal detectable levels of TGF-a mRNA
(2) . However, Gottlieb et al . (5), using a mAb (mAb A1.5)
against human TGF-a, detectedTGF-a in cells in the dermal
infiltrates associated with inflammatory, hyperproliferative
(psoriasis), and neoplastic skin diseases . Although the iden-
tity of the TGF-a positive cells was not determined, Gott-
lieb et al . suggested that they may have been macrophages,
Langerhan's cells, and/or activated T cells.
In our specimens, eosinophils represented the only iden-
tifiable infiltrating leukocyte positive for TGF-amRNA by
in situ hybridization . Moreover, PCR restriction enzyme anal-
ysis, immunohistochemistry, andRIA suggest that eosinophils
express the mature, biologically active, form of the cytokine .
Eosinophils thusmay represent a major nonepithelial source
ofTGF-a . On the other hand, it remains to be established
whether the form ofTGF-a expressed by eosinophils is fully
identical in structure and pattern of biological activity to
TGF-a derived from other sources .
We found that TGF-amRNA was detectable in -90%
of tumor-associated eosinophils and in the majority (80%)
of the eosinophils isolated from our patient with the idio-
pathic hypereosinophilic syndrome . By immunohistochem-
istry, 55% of the eosinophils purified from the hypereo-
sinophilic patient were positive for TGF-ca product . By
contrast, none ofeosinophils purified from the peripheral blood
of normal donors exhibited detectable TGF-a product and
most of them lacked detectable TGF-amRNA . Indeed, no
eosinophils positive for TGF-a mRNA were detectable in
five of the seven normal donors . On the other hand, in the
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two donors who had peripheral blood leukocytes positive for
TGF-a mRNA, all of the positive cells were eosinophils .
Thus, the majority of the peripheral blood eosinophils of
normal donors, as well as subpopulations of eosinophils from
the hypereosinophilic patient or in the infiltrates associated
with carcinomas, lacked detectable expression ofTGF-a . These
findings raise the possibility that the expression of TGF-ot
by eosinophils is subject to microenvironmental regulation .
This would not be surprising, in view ofwhat is known about
the expression ofTGF-a or other pleuripotential cytokines
by other cell types. For example, TGF-a expression can be
detected in human alveolar macrophages stimulated with LPS,
but not in the unstimulated cells (9) . Similarly, the expres-
sion by mouse mast cells ofmRNA or product for a wide
variety of cytokines is markedly augmented when the cells
are stimulated via the IgE receptor (32-35) . Finally, human
eosinophils have been shown to synthesize specific proteins
upon appropriate stimulation in vitro. When eosinophils
purified from nine donors were examined forHLADR ex-
pression by flow cytometry, the cells of eight donors lacked
HLADR expression and only 23% of the eosinophils of the
ninth donor exhibited the antigen. But when the eosinophils
were tested after incubation in vitro with recombinanthuman
granulocyte/macrophage colony-stimulating factor (rhGM-
CSF) and3T3 fibroblasts, HLADR expression was induced
on eosinophils from each donor (23) .
It will clearly be of interest to search for factors that influence
TGF-a expression by eosinophils. While such studies will
be important for identifying the specific signals regulating
TGF-a expression by eosinophils, we already have demon-
strated that TGF-a mRNA is present in the majority of eo-
sinophils infiltrating four spontaneous neoplasms occurring
in two distinct anatomical sites in four different patients . This
finding indicates that the expression ofTGF-a by tissue eo-
sinophils may not be an unusual occurrence, and permits specu-
lation about novel mechanisms by which eosinophils might
affect epithelial proliferation during physiological or patho-
logical responses.
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